Literature DB >> 16603716

Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Emily A Newman1, Stephanie J Muh, Ruben H Hovhannisyan, Claude C Warzecha, Richard B Jones, Wallace L McKeehan, Russ P Carstens.   

Abstract

We have developed a series of fluorescent splicing reporter minigenes for the establishment of cell-based screens to identify splicing regulatory proteins. A key technical advance in the application of these reporters was the use of two different fluorescent proteins: EGFP and monomeric Red Fluorescent Protein (mRFP). Through establishment of stable cell lines expressing such dual color fluorescent reporters, these minigenes can be used to perform enhanced screens for splicing regulatory proteins. As an example of such applications we generated fluorescent minigenes that can be used to determine the splicing of mutually exclusive FGFR2 exons IIIb and IIIc by flow cytometry. One minigene contained a coding sequence for EGFP whose translation was dependent on splicing of exon IIIb, whereas a second minigene required exon IIIc splicing for translation of an mRFP coding sequence. Stable incorporation of both minigenes into cells that express endogenous FGFR2-IIIb or FGFR2-IIIc resulted in EGFP or mRFP fluorescence, respectively. Cells stably transfected with both minigenes were used to screen a panel of cDNAs encoding known splicing regulatory proteins, and several were identified that induced a switch in splicing that could be detected specifically by an increase in green, but not red, fluorescence. We further demonstrated additional minigenes that can be used in dual color fluorescent screens for identification of splicing regulatory proteins that function through specific intronic splicing enhancer elements (ISEs). The methods and minigene designs described here should be adaptable for broader applications in identification of factors and mechanisms involved in alternative splicing of numerous other gene transcripts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603716      PMCID: PMC1464843          DOI: 10.1261/rna.34906

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  60 in total

1.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing.

Authors:  Andrea N Ladd; Nicole H Nguyen; Kavin Malhotra; Thomas A Cooper
Journal:  J Biol Chem       Date:  2004-02-03       Impact factor: 5.157

3.  Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.

Authors:  Jason M Johnson; John Castle; Philip Garrett-Engele; Zhengyan Kan; Patrick M Loerch; Christopher D Armour; Ralph Santos; Eric E Schadt; Roland Stoughton; Daniel D Shoemaker
Journal:  Science       Date:  2003-12-19       Impact factor: 47.728

Review 4.  Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA.

Authors:  Cyril F Bourgeois; Fabrice Lejeune; James Stévenin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

Review 5.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

6.  Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by alpha-tropomyosin regulatory elements in transgenic mice.

Authors:  Peter D Ellis; Christopher W J Smith; Paul Kemp
Journal:  J Biol Chem       Date:  2004-06-11       Impact factor: 5.157

Review 7.  Splice variants as cancer biomarkers.

Authors:  Brigitta M N Brinkman
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

8.  Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.

Authors:  Jian-Hua Ding; Xiangdong Xu; Dongmei Yang; Pao-Hsien Chu; Nancy D Dalton; Zhen Ye; Joanne M Yeakley; Heping Cheng; Rui-Ping Xiao; John Ross; Ju Chen; Xiang-Dong Fu
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

9.  Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment.

Authors:  Lijian Hui; Xin Zhang; Xin Wu; Zhixin Lin; Qingkang Wang; Yixue Li; Gengxi Hu
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

Review 10.  Analysis of alternative splicing with microarrays: successes and challenges.

Authors:  Christopher Lee; Meenakshi Roy
Journal:  Genome Biol       Date:  2004-06-21       Impact factor: 13.583

View more
  23 in total

1.  Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans.

Authors:  Hidehito Kuroyanagi; Genta Ohno; Hiroaki Sakane; Hiroyuki Maruoka; Masatoshi Hagiwara
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

2.  STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo.

Authors:  Genta Ohno; Masatoshi Hagiwara; Hidehito Kuroyanagi
Journal:  Genes Dev       Date:  2008-01-29       Impact factor: 11.361

3.  Imaging the alternative silencing of FGFR2 exon IIIb in vivo.

Authors:  Vivian I Bonano; Sebastian Oltean; Robert M Brazas; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2006-10-26       Impact factor: 4.942

4.  Enzymatic measurement of phosphatidylserine in cultured cells.

Authors:  Shin-ya Morita; Sachimi Shirakawa; Yukiko Kobayashi; Keiko Nakamura; Reiko Teraoka; Shuji Kitagawa; Tomohiro Terada
Journal:  J Lipid Res       Date:  2011-11-18       Impact factor: 5.922

5.  A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators.

Authors:  Peter Stoilov; Chia-Ho Lin; Robert Damoiseaux; Julia Nikolic; Douglas L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

6.  Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection.

Authors:  Akihide Takeuchi; Motoyasu Hosokawa; Takayuki Nojima; Masatoshi Hagiwara
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

7.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Authors:  Claude C Warzecha; Trey K Sato; Behnam Nabet; John B Hogenesch; Russ P Carstens
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

8.  The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation.

Authors:  Victoria A Barron; Hui Zhu; Melissa N Hinman; Andrea N Ladd; Hua Lou
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

Review 9.  Fox-1 family of RNA-binding proteins.

Authors:  Hidehito Kuroyanagi
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

10.  Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.

Authors:  Rui Wang; Ronald G Crystal; Neil R Hackett
Journal:  BMC Mol Biol       Date:  2009-11-17       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.